INS and diabetes mellitus: Protein/peptide approaches can be augmented through coupling of toxins to diabetes-relevant antigens, with oral and nasal administration of cholera toxin B-coupled insulin reducing islet inflammation and disease onset in NOD mice through a mechanism that involves downregulation of CD86 and increased IL-10 expression by DCs (250–253).